120 related articles for article (PubMed ID: 23823657)
21. [Myelodysplastic syndrome in children].
Yoshimi-Noellke A
Rinsho Ketsueki; 2009 Oct; 50(10):1560-9. PubMed ID: 19915367
[No Abstract] [Full Text] [Related]
22. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
Ji J; Navid F; Hiemenz MC; Kaneko M; Zhou S; Saitta SC; Biegel JA
Cancer Genet; 2019 Feb; 231-232():62-66. PubMed ID: 30803559
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
Bunda S; Kang MW; Sybingco SS; Weng J; Favre H; Shin DH; Irwin MS; Loh ML; Ohh M
Cancer Res; 2013 Apr; 73(8):2540-50. PubMed ID: 23400592
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of juvenile myelomonocytic leukemia.
de Vries AC; Zwaan CM; van den Heuvel-Eibrink MM
Haematologica; 2010 Feb; 95(2):179-82. PubMed ID: 20139388
[No Abstract] [Full Text] [Related]
25. [Juvenile myelomonocytic leukemias].
Lachenaud J; Strullu M; Baruchel A; Cavé H
Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
[TBL] [Abstract][Full Text] [Related]
26. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
Baccelli F; Leardini D; Muratore E; Messelodi D; Bertuccio SN; Chiriaco M; Cancrini C; Conti F; Castagnetti F; Pedace L; Pession A; Yoshimi A; Niemeyer C; Tartaglia M; Locatelli F; Masetti R
Hum Genomics; 2022 Sep; 16(1):40. PubMed ID: 36123612
[TBL] [Abstract][Full Text] [Related]
27. [Molecular biology of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2010 Jul; 51(7):526-31. PubMed ID: 20693772
[No Abstract] [Full Text] [Related]
28. Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
Hanson HL; Wilson MJ; Short JP; Chioza BA; Crosby AH; Nash RM; Marks KJ; Mansour S
Am J Med Genet A; 2014 Apr; 164A(4):1003-9. PubMed ID: 24458550
[TBL] [Abstract][Full Text] [Related]
29. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL.
Gagne AL; Maguire JA; Gandre-Babbe S; Chou ST; Tasian SK; Loh ML; Weiss MJ; Gadue P; French DL
Stem Cell Res; 2018 Aug; 31():157-160. PubMed ID: 30096712
[TBL] [Abstract][Full Text] [Related]
30. RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia.
Lanzarotti N; Bruneau J; Trinquand A; Stolzenberg MC; Neven B; Fregeac J; Levy E; Jeremiah N; Suarez F; Mahlaoui N; Fischer A; Magerus-Chatinet A; Cavé H; Rieux-Laucat F
Blood; 2014 Mar; 123(12):1960-3. PubMed ID: 24652966
[No Abstract] [Full Text] [Related]
31. A case of splenomegaly in CBL syndrome.
Coe RR; McKinnon ML; Tarailo-Graovac M; Ross CJ; Wasserman WW; Friedman JM; Rogers PC; van Karnebeek CDM
Eur J Med Genet; 2017 Jul; 60(7):374-379. PubMed ID: 28414188
[TBL] [Abstract][Full Text] [Related]
32. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
[TBL] [Abstract][Full Text] [Related]
33. A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers.
Norris GA; Tsai AC; Schneider KW; Wu YH; Caulfield T; Green AL
Cancer Genet; 2021 Jun; 254-255():18-24. PubMed ID: 33550024
[TBL] [Abstract][Full Text] [Related]
34. A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing.
Wang WH; Lu MY; Tsai CH; Wang SC; Chou SW; Jou ST
J Formos Med Assoc; 2021 Apr; 120(4):1148-1152. PubMed ID: 32933826
[TBL] [Abstract][Full Text] [Related]
35. Long-term remission of infantile Takayasu arteritis associated with germline CBL syndrome after allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Munoz-Osores E; Piñones M; Barriga F; Wietstruck MA; Pérez-Mateluna G; Mellado C; Aracena M; Parra R; García C; Borzutzky A
Transpl Immunol; 2024 Apr; 83():102013. PubMed ID: 38395087
[TBL] [Abstract][Full Text] [Related]
36. Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report.
Yao R; Yu T; Xu Y; Li G; Yin L; Zhou Y; Wang J; Yan Z
BMC Med Genomics; 2018 Jul; 11(1):60. PubMed ID: 30012129
[TBL] [Abstract][Full Text] [Related]
37. Aggressive congenital juvenile myelomonocytic leukemia associated with somatic KRAS p.G13D mutation and concurrent germline IGF1R duplication.
Kothari A; Hulbert ML; Cottrell CE; Nguyen TT
Leuk Lymphoma; 2015 Apr; 56(4):1175-8. PubMed ID: 25110823
[No Abstract] [Full Text] [Related]
38. Transient immune deficiency accompanied with homozygous CBL rare variant.
Morishita A; Yeh TW; Tomari K; Furuichi M; Kashimada K; Morio T; Takagi M; Imai K
Pediatr Int; 2023 Jan; 65(1):e15439. PubMed ID: 36495474
[TBL] [Abstract][Full Text] [Related]
39. Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia.
Prontera P; Pantaleoni F; Martinelli S; Mastrodicasa E; Stangoni G; Barboni G; Tartaglia M; Aversa F; Donti E
Leuk Res; 2011 Mar; 35(3):e13-4. PubMed ID: 21106241
[No Abstract] [Full Text] [Related]
40. [Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].
Manabe A
Rinsho Ketsueki; 2012 Aug; 53(8):729-33. PubMed ID: 22975811
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
